Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations

NCT03454919 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Palbociclib

Sponsor

Peking University Cancer Hospital & Institute

Collaborators

[object Object]